Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

By sjmartinez • November 15, 2022

Turbyfill C, Adams K, Tenforde MW, Murray NL, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Keipp Talbot H, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Clark Files D, Hager DN, Shehu A, Prekker ME, Frosch AE, Exline MC, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Lauring AS, Khan A, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, June Gordon A, Qadir N, Chang SY, Mallow C, Rivas C, Kwon JH, Halasa N, Chappell JD, Grijalva CG, Rice TW, Stubblefield WB, Baughman A, Rhoads JP, Lindsell CJ, Hart KW, McMorrow M, Surie D, Self WH, Patel MM. Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. Vaccine. 2022 Nov 15;40(48):6979-6986. doi: 10.1016/j.vaccine.2022.10.034. Epub 2022 Oct 24. PMID: 36374708.

Tags: case-control study, Control groups, covid-19, Publications, Pulmonary, Critical Care & Sleep Medicine, Research design, Test-negative, vaccine effectiveness

The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease

Kim SG, Zhao MY, Lam C, Jacobs JP. The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease. Gastroenterol Clin North Am. 2026 Mar;55(1):165-184. doi: 10.1016/j.gtc.2025.10.003.[...]

Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use

Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21.[...]

Amara Yad Image: 2-Chamber View of the Left Heart-Lateral Segment

Shivkumar K, Mori S. Amara Yad Image: 2-Chamber View of the Left Heart-Lateral Segment. J Am Coll Cardiol. 2025 Dec 16;86(24):2535-2537. doi: 10.1016/j.jacc.2025.10.039. Epub 2025[...]